Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma? (European Journal of Pediatrics DOI: 10.1007/s00431-007-0644-3);Inhaled corticosteroids or montelukast as the preferred primary long-term treatment for pediatric asthma?

European Journal of Pediatrics

Volumn 167, Issue 7, 2008, Pages 731-736

  Jartti, Tuomas ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Asthma; Child; Fluticasone; Inhaled corticosteroid; Leukotriene receptor antagonist; Montelukast; Treatment

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CROMOGLYCATE DISODIUM; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; METHACHOLINE; MONTELUKAST; PLACEBO; SALBUTAMOL;

ADD ON THERAPY; ALLERGY; ASTHMA; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; COST BENEFIT ANALYSIS; DISEASE MARKER; DISEASE SEVERITY; DRUG EFFICACY; DRUG RESPONSE; FORCED EXPIRATORY VOLUME; FUNDING; HUMAN; LONG TERM CARE; LOW DRUG DOSE; LUNG FUNCTION; MONOTHERAPY; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REVIEW; TREATMENT DURATION;

EID: 44349107702     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00431-008-0699-9     Document Type: Erratum

References (22)

1. van Adelsberg J, Moy J, Wei LX, Tozzi CA, Knorr B, Reiss TF (2005) Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma. Curr Med Res Opin 21:971-979
2. Bisgaard H, Nielsen KG (2000) Bronchoprotection with a leukotriene receptor antagonist in asthmatic preschool children. Am J Respir Crit Care Med 162:187-190
3. Bisgaard H, Zielen S, Garcia-Garcia ML, Johnston SL, Gilles L, Menten J, Tozzi CA, Polos P (2005) Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 171:315-322
4. Buchvald F, Bisgaard H (2003) Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide. Ann Allergy Asthma Immunol 91:309-313
5. Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, Kuderer NM, Lyman GH (2000) The uncertainty principle and industry-sponsored research. Lancet 356:635-638
6. Garcia Garcia ML, Wahn U, Gilles L, Swern A, Tozzi CA, Polos P (2005) Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 116:360-369
7. Ghiro L, Zanconato S, Rampon O, Piovan V, Pasquale MF, Baraldi E (2002) Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children. Eur Respir J 20:630-634
8. Goodman DC (2005) When an asthma drug has an inferiority complex: a noninferiority trial. Pediatrics 116:493-495
9. Johnston NW, Mandhane PJ, Dai J, Duncan JM, Greene JM, Lambert K, Sears MR (2007) Montelukast added to usual therapy during the September epidemic of asthma exacerbations in children. J Allergy Clin Immunol 119:S4
10. Kemp JP, Dockhorn RJ, Shapiro GG, Nguyen HH, Reiss TF, Seidenberg BC, Knorr B (1998) Montelukast once daily inhibits exercise-induced bronchoconstriction in 6- to 14-year-old children with asthma. J Pediatr 133:424-428
11. Knorr B, Matz J, Bernstein JA, Nguyen H, Seidenberg BC, Reiss TF, Becker A (1998) Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA 279:1181-1186
12. Knorr B, Franchi LM, Bisgaard H, Vermeulen JH, LeSouef P, Santanello N, Michele TM, Reiss TF, Nguyen HH, Bratton DL (2001) Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 108:E48
13. Melo RE, Solé D, Naspitz CK (2003) Exercise-induced bronchoconstriction in children: montelukast attenuates the immediate-phase and late-phase responses. J Allergy Clin Immunol 111:301-307
14. Meyer KA, Arduino JM, Santanello NC, Knorr BA, Bisgaard H (2003) Response to montelukast among subgroups of children aged 2 to 14 years with asthma. J Allergy Clin Immunol 111:757-762
15. National Heart, Lung, and Blood Institute (2007) Expert Panel Report 3: guidelines for the diagnosis and management of asthma. Full report, available online at http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf
16. Ostrom NK, Decotiis BA, Lincourt WR, Edwards LD, Hanson KM, Carranza Rosenzweig JR, Crim C (2005) Comparative efficacy and safety of low-dose fluticasone propionate and montelukast in children with persistent asthma. J Pediatr 147:213-220
17. Phipatanakul W, Greene C, Downes SJ, Cronin B, Eller TJ, Schneider LC, Irani AM (2003) Montelukast improves asthma control in asthmatic children maintained on inhaled corticosteroids. Ann Allergy Asthma Immunol 91:49-54
18. Scottish Intercollegiate Guidelines Network (SIGN) The British Thoracic Society (2007) British guideline on the management of asthma. Available online at http://www.sign.ac.uk/guidelines/fulltext/63/index.html
19. Sorkness CA, Lemanske RF Jr, Mauger DT, Boehmer SJ, Chinchilli VM, Martinez FD, Strunk RC, Szefler SJ, Zeiger RS, Bacharier LB, Bloomberg GR, Covar RA, Guilbert TW, Heldt G, Larsen G, Mellon MH, Morgan WJ, Moss MH, Spahn JD, Taussig LM; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute (2007) Long-term comparison of 3 controller regimens for mild-moderate persistent childhood asthma: the Pediatric Asthma Controller Trial. J Allergy Clin Immunol 119:64-72
20. Spahn JD, Covar RA, Jain N, Gleason M, Shimamoto R, Szefler SJ, Gelfand EW (2006) Effect of montelukast on peripheral airflow obstruction in children with asthma. Ann Allergy Asthma Immunol 96:541-549
21. Szefler SJ, Phillips BR, Martinez FD, Chinchilli VM, Lemanske RF, Strunk RC, Zeiger RS, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM (2005) Characterization of within-subject responses to fluticasone and montelukast in childhood asthma. J Allergy Clin Immunol 115:233-242
22. Zeiger RS, Szefler SJ, Phillips BR, Schatz M, Martinez FD, Chinchilli VM, Lemanske RF Jr, Strunk RC, Larsen G, Spahn JD, Bacharier LB, Bloomberg GR, Guilbert TW, Heldt G, Morgan WJ, Moss MH, Sorkness CA, Taussig LM; Childhood Asthma Research and Education Network of the National Heart, Lung, and Blood Institute (2006) Response profiles to fluticasone and montelukast in mild-to-moderate persistent childhood asthma. J Allergy Clin Immunol 117:45-52